Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180610040036N1Phase 3Completed
Phase 3, randomised, double-blind trial of clofibride in jaundice (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Total serum bilirubin. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180610040036N1.